Ontology highlight
ABSTRACT: Objectives
This study examines the characteristics of studies that Health Canada uses to grant full marketing authorisation for products given a conditional approval between 1 January 1998 and 30 June 2017.Design
Cohort study.Data sources
Journal articles listing drugs that fulfilled their conditions and received full marketing authorisation, Notice of Compliance database, Notice of Compliance with conditions website, Qualifying Notices listing required confirmatory studies, clinicaltrials.gov, PubMed, Embase, companies making products being analysed, journal articles resulting from confirmatory studies.Interventions
None.Primary and secondary outcome measures
Characteristics of studies-study design (randomised controlled trials, observational), prim
SUBMITTER: Lexchin J
PROVIDER: S-EPMC5931291 | biostudies-literature | 2018 Apr
REPOSITORIES: biostudies-literature